Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

SCYNEXIS, Inc.

SCYXNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.90
$0.04(4.68%)
U.S. Market opens in 15h 54m

SCYNEXIS, Inc. (SCYX) Stock Overview

Explore SCYNEXIS, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap40.2M
P/E Ratio-4.39
EPS (TTM)$-0.17
ROE-0.19%
Fundamental Analysis

AI Price Forecasts

1 Month$0.87
3 Months$1.09
1 Year Target$0.21

SCYX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of SCYNEXIS, Inc. (SCYX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 65.24, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.21.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -4.39 and a market capitalization of 40.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
4.68%
5-Day Change
-0.11%
1-Month Change
18.29%
3-Month Change
42.43%
6-Month Change
-15.19%
Year-to-Date (YTD) Change
40.80%
1-Year Change
-18.27%
3-Year Change
-29.77%
5-Year Change
-89.45%
All-Time (Max) Change
-99.00%

Contact Information

201 884 5485
1 Evertrust Plaza, Jersey City, NJ, 07302-6548

Company Facts

280 Employees
IPO DateMay 2, 2014
CountryUS
Actively Trading

Frequently Asked Questions